Research Topic · Peer-Reviewed

Chemotherapy Regimens

Chemotherapy regimens are defined treatment protocols that specify the cytotoxic and related antineoplastic drugs used to treat cancer, together with their doses, routes of administration, sequence, and the timing and number of cycles. Rather than a single agent, regimens often combine drugs with complementary mecha…

Curated from this journal's research 📚 5 peer-reviewed articles cited Cited 5× across the literature 🗓 Reviewed June 2026

Overview

Chemotherapy regimens are defined treatment protocols that specify the cytotoxic and related antineoplastic drugs used to treat cancer, together with their doses, routes of administration, sequence, and the timing and number of cycles. Rather than a single agent, regimens often combine drugs with complementary mechanisms of action to increase tumour-cell kill, target different phases of the cell cycle, and reduce the emergence of drug resistance, while spacing cycles to allow recovery of normal tissues. Regimens are selected according to tumour type, stage, molecular characteristics, and patient factors, and they may be given with curative or palliative intent. They are frequently integrated into multimodal treatment, used before surgery as neoadjuvant therapy to reduce tumour burden, after surgery as adjuvant therapy to eradicate residual disease, or in combination with radiotherapy, targeted agents, and immunotherapy. A defining challenge of regimen design is the balance between antitumour efficacy and toxicity, since cytotoxic drugs affect proliferating normal tissues, producing dose-limiting effects such as myelosuppression and disruption of haematopoiesis, alongside other organ-specific toxicities. Regimen development therefore considers drug interactions, dose intensity and scheduling, supportive care, and management across diverse settings and patient populations to optimise outcomes while limiting harm.

Research published in this journal

5 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2022

Primary Breast Sarcoma

Y. Fernando GracieuxCorresponding author
Consultant, Section of Medical Oncology-Department of Internal Medicine, University of the Philippines-College of Medicine Philippine General Hospital, Manila
Clinical Case Reports and Images Cited by 1 doi:10.14302/issn.2641-5518.jcci-22-4323

How this research is being cited

The 5 articles above have been cited 5 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Chemotherapy Regimens, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in International Journal of Chemotherapy Research and Practice.

Journal editorial board
Monika Sakowicz-Burkiewicz · Poland M. Waheed Roomi · United States Silvia Lemma · Italy

This page summarises published research for orientation; it is not medical or professional advice.